Detalhe da pesquisa
1.
Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO.
Breast Cancer Res Treat
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689174
2.
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.
Ann Oncol
; 34(8): 645-659, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269905
3.
ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5).
Ann Oncol
; 33(11): 1097-1118, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35934170
4.
ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4).
Ann Oncol
; 31(6): 674-696, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32199930
5.
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning.
Semin Cancer Biol
; 52(Pt 2): 151-157, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29990622
6.
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer.
Ann Oncol
; 29(1): 162-169, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29077781
7.
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation.
Ann Oncol
; 29(8): 1800-1806, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860358
8.
Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.
Breast Cancer Res Treat
; 168(2): 551-557, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29235045
9.
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.
Ann Oncol
; 28(2): 321-328, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28426105
10.
Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer.
Ann Oncol
; 27(2): 249-56, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26598540
11.
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.
Ann Oncol
; 26(4): 682-687, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25600567
12.
Primary tumor somatic mutations in the blood of women with ductal carcinoma in situ of the breast.
Ann Oncol
; 31(3): 435-437, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32067686
13.
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.
Ann Oncol
; 26(2): 259-71, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25214542
14.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).
Ann Oncol
; 26(5): 873-879, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25725046
15.
Gene expression profiling reveals GC and CEACAM1 as new tools in the diagnosis of lung carcinoids.
Br J Cancer
; 110(5): 1244-9, 2014 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24518592
16.
Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials.
Ann Oncol
; 25(3): 618-623, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24351403
17.
Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
ESMO Open
; 9(3): 102390, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460249
18.
Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00.
Eur J Cancer
; 200: 113535, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309015
19.
The effect of metformin on apoptosis in a breast cancer presurgical trial.
Br J Cancer
; 109(11): 2792-7, 2013 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24157825
20.
Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype.
Br J Cancer
; 108(8): 1593-601, 2013 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23579208